Energy Services of America Corporation (the “Company” or “Energy Services”) (Nasdaq: ESOA), today announced its results for its fiscal third quarter ended June 30, 2025. https://mma.prnewswire.com/media/2747932/ESA_Logo.jpg Third Quarter Summary (1) — Revenue of $103.6 million, a 21% increase — Gross profit of $12.0 million, compared to $15.3 million — Net income of $2.1 million, or […]
Jack Henry & Associates, Inc.® (Nasdaq: JKHY) announced today that deconversion revenue for the fiscal fourth quarter, ended June 30, 2025, was $20.5 million. This brought total deconversion revenue for full year fiscal 2025 to $33.9 million. For more information about how guidance is developed for deconversion revenue estimates, please see Jack Henry's Current Report
(NasdaqGM:BBOT), Business combination transaction with Helix Acquisition Corp. II, a special purpose acquisition company sponsored by affiliates of Cormorant Asset Management, completed on August 11, 2025 Closed concurrent $261 million private investment in public equity (“PIPE”), led by Cormorant Combining approximately $120 million from the former Helix II trust account (reflecting a final redemption rate
(NYSE:HRB), Jeffrey J. Jones II to Retire After Eight Years; Will Remain Strategic Advisor Curtis Campbell, President of Global Consumer Tax and Chief Product Officer at H&R Block, Named CEO-Elect Appointment Comes After Rigorous Succession Planning Process KANSAS CITY, Mo., Aug. 11, 2025 (GLOBE NEWSWIRE) — H&R Block, Inc. (NYSE: HRB) (the “Company”) today announced
(NASDAQ:JJSF), MOUNT LAUREL, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) — J & J Snack Foods Corp. (NASDAQ: JJSF) announced today that its Board of Directors has declared a quarterly cash dividend of $0.80 per share of its common stock payable on October 7, 2025, to shareholders of record as of the close of business on
(NYSE MKT:SER), HUNTSVILLE, Aug. 11, 2025 (GLOBE NEWSWIRE) — Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company advancing its lead IND candidate, SER-252, for advanced Parkinson's disease, enabled by its proprietary POZ Platform(TM) drug optimization technology, today announced its financial results for the second quarter ended June 30, 2025, along with key
(NASDAQ:NVCT), The Phase 1b program is designed to evaluate the clinical activity of NXP900 as a single agent in patients with advanced solid tumors whose cancers harbor specific genetic alterations, and in combination with EGFR and ALK inhibitors in patients with NSCLC whose cancers developed resistance to these treatments Nuvectis will hold a conference call
(NasdaqGM:RGCO), ROANOKE, Va., Aug. 11, 2025 (GLOBE NEWSWIRE) — RGC Resources, Inc. (Nasdaq: RGCO) announced consolidated earnings of $538,412, or $0.05 per share, for the third quarter ended June 30, 2025, compared to $156,692, or $0.02 per share, for the fiscal quarter ended June 30, 2024. The increase during the quarter was largely the result
(NASDAQ:HTFL), MOUNTAIN VIEW, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) — Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), a leader in AI technology for coronary artery disease (CAD), today announced the closing of its upsized initial public offering of 19,166,667 shares of its common stock at a public offering price of $19 per share, which includes 2,500,000 shares
(NASDAQ:LTBR),(NYSE:OKLO), RESTON, Va., Aug. 11, 2025 (GLOBE NEWSWIRE) — Lightbridge Corporation (“Lightbridge” or the “Company”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, and Oklo Inc. (NYSE: OKLO), an advanced nuclear technology company, today announced a strategic collaboration to explore the potential co-location of a Lightbridge fuel fabrication facility within Oklo's planned advanced fuel manufacturing